Expanding the role of clinical pharmacists on interdisciplinary primary care teams for chronic pain and opioid management

Karleen F Giannitrapani, Peter A Glassman, Derek Vang, Jeremiah C McKelvey, R Thomas Day, Steven K Dobscha, Karl A Lorenz, Karleen F Giannitrapani, Peter A Glassman, Derek Vang, Jeremiah C McKelvey, R Thomas Day, Steven K Dobscha, Karl A Lorenz

Abstract

Background: Facilitating appropriate and safe prescribing of opioid medications for chronic pain management in primary care is a pressing public health concern. Interdisciplinary team-based models of primary care are exploring the expansion of clinical pharmacist roles to support disease management for chronic conditions, e.g. pain. Our study aims to 1) identify roles clinical pharmacists can assume in primary care team based chronic pain care processes and 2) understand the barriers to assuming these expanded roles.

Methods: Setting: Veterans Health Administration (VA) has implemented an interdisciplinary team-based model for primary care which includes clinical pharmacists.

Design: We employed an inductive two part qualitative approach including focus groups and semi-structured interviews with key informants.

Participants: 60 members of VA primary care teams in two states participated in nine preliminary interdisciplinary focus groups where a semi-structured interview guide elucidated provider experiences with screening for and managing chronic pain. To follow up on emergent themes relating to clinical pharmacist roles, an additional 14 primary care providers and clinical pharmacists were interviewed individually. We evaluated focus group and interview transcripts using the method of constant comparison and produced mutually agreed upon themes.

Results: Clinical pharmacists were identified by primary care providers as playing a central role with the ongoing management of opioid therapy including review of the state prescription drug monitoring program, managing laboratory screening, providing medication education, promoting naloxone use, and opioid tapering. Specific barriers to clinical pharmacists role expansion around pain care include: limitations of scopes of practice, insufficient institutional support (low staffing, dedicated time, insufficient training, lack of interdisciplinary leadership support), and challenges and opportunities for disseminating clinical pharmacists' expanded roles.

Conclusions: Expanding the role of the clinical pharmacist to collaborate with providers around primary care based chronic pain management is a promising strategy for improving pain management on an interdisciplinary primary care team. However, expanded roles have to be balanced with competing responsibilities relating to other conditions. Interdisciplinary leadership is needed to facilitate training, resources, adequate staffing, as well as to prepare both clinical pharmacists and the providers they support, about expanded clinical pharmacists' scopes of practice and capabilities.

Keywords: Clinical pharmacists; Interdisciplinary teams; Pain; Pain management; Qualitative research; Team based care.

Conflict of interest statement

Ethics approval and consent to participate

The study protocol was approved by the Veterans Affairs Central Institutional Review Board, Project ID 13–08. All interviews were done on the phone. Verbal consent to participate and record all focus groups and interviews was obtained at the beginning of each session as approved by the Institutional Review Board.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

    1. Melzack R, Wall PD. Pain mechanisms: a new theory. Science. 1965;150(3699):971–979. doi: 10.1126/science.150.3699.971.
    1. Goldberg DS, McGee SJ. Pain as a global public health priority. BMC Public Health. 2011;11:770. doi: 10.1186/1471-2458-11-770.
    1. Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain—United States, 2016. JAMA. 2016;315:1624. doi: 10.1001/jama.2016.1464.
    1. Brennan F, Carr DB, Cousins M. Pain management: a fundamental human right. Anesth Analg. 2007;105(1):205–221. doi: 10.1213/01.ane.0000268145.52345.55.
    1. Lasser KE, Shanahan C, Parker V, Beers D, Xuan Z, Heymann O, et al. A multicomponent intervention to improve primary care provider adherence to chronic opioid therapy guidelines and reduce opioid misuse: a cluster randomized controlled trial protocol. J Subst Abus Treat. 2016;60:101–109. doi: 10.1016/j.jsat.2015.06.018.
    1. Upshur CC, Bacigalupe G, Luckmann R. “They don't want anything to do with you”: patient views of primary care management of chronic pain. Pain Med. 2010;11(12):1791–1798. doi: 10.1111/j.1526-4637.2010.00960.x.
    1. Richardson LM, Hill JN, Smith BM, Bauer E, Weaver FM, Gordon HS, et al. Patient prioritization of comorbid chronic conditions in the veteran population: implications for patient-centered care. SAGE Open Medicine. 2016;4:2050312116680945. doi: 10.1177/2050312116680945.
    1. Veterans Health Administration. About VHA. U.S. Washington DC: Department of Veterans Affairs; 2018. . Accessed 2 Feb 2018.
    1. Reiss-Brennan B, Brunisholz KD, Dredge C, Briot P, Grazier K, Wilcox A, et al. Association of integrated team-based care with health care quality, utilization, and cost. JAMA. 2016;316(8):826–834. doi: 10.1001/jama.2016.11232.
    1. Dobscha SK, Corson K, Perrin NA, Hanson GC, Leibowitz RQ, Doak MN, et al. Collaborative care for chronic pain in primary care: a cluster randomized trial. JAMA. 2009;301(12):1242–1252. doi: 10.1001/jama.2009.377.
    1. VHA Patient Aligned Care Team (PACT) Handbook. Washington, DC: Affairs V; 2014.
    1. VHA Directive 1139: Palliative Care Consult Teams (PCCT) and VISN Leads. Washington DC: Department of Veterans Affairs; 2017.
    1. DeBar LL, Kindler L, Keefe FJ, Green CA, Smith DH, Deyo RA, et al. A primary care-based interdisciplinary team approach to the treatment of chronic pain utilizing a pragmatic clinical trials framework. Translational behavioral medicine. 2012;2(4):523–530. doi: 10.1007/s13142-012-0163-2.
    1. Atkinson J, de Paepe K, Sánchez Pozo A, Rekkas D, Volmer D, Hirvonen J, et al. What is a pharmacist: opinions of pharmacy department academics and community pharmacists on competences required for pharmacy practice. Pharmacy. 2016;4(1):12. doi: 10.3390/pharmacy4010012.
    1. VHA. Handbook 1108.11: Clinical Pharmacy Services; 2017.
    1. VHA. Directive 2009–053: Pain Management; 2009.
    1. Rapoport A, Akbik H. Pharmacist-managed pain clinic at a veterans affairs medical center. Am J Health Syst Pharm. 2004;61(13):1341–1343.
    1. Jouini G, Choinière M, Martin E, Perreault S, Berbiche D, Lussier D, et al. Pharmacotherapeutic management of chronic noncancer pain in primary care: lessons for pharmacists. J Pain Res. 2014;7:163–173.
    1. Effective Screening for Pain Study. . 2013; Identifier: NCT01816763.
    1. Giannitrapani K, Ahluwalia S, McCaa M, Pisciotta M, Dobscha S, Lorenz K. Barriers to using nonpharmacologic approaches and reducing opioid use in primary care. Pain Med. 2017. [Epub ahead of print].
    1. Giannitrapani KF, Ahluwalia SC, Day RT, Pisciotta M, Dobscha S, Lorenz K. Challenges to teaming for pain in primary care. Healthcare. 2018;6:23–7. doi: 10.1016/j.hjdsi.2017.06.006.
    1. Ahluwalia SC, Giannitrapani KF, Dobscha SK, Cromer R, Lorenz KA. “It Encourages Them to Complain”: a qualitative study of the unintended consequences of assessing patient-reported pain. J Pain. 2018;19:562–8.
    1. ATLAS.ti Scientific Software Development GmbH, Berlin, Version 7.1.0.
    1. Glaser BJ, Strauss AL. The discovery of grounded theory: strategies for qualitative research. NY: Adeline Publishing Company; 1967.
    1. Bernard HR. Research methods in anthropology: qualitative and quantitative methods. Walnut Creek, CA: AltaMira Press; 2002.
    1. Ghorob A, Bodenheimer T. Share the care: building teams in primary care practices. J Am Board Fam Med. 2012;25(2):143–145. doi: 10.3122/jabfm.2012.02.120007.
    1. Smith M, Bates DW, Bodenheimer T, Cleary PD. Why pharmacists belong in the medical home. Health Aff. 2010;29(5):906–913. doi: 10.1377/hlthaff.2010.0209.
    1. Cox N, Tak CR, Cochella SE, Leishman E, Gunning K. Impact of pharmacist previsit input to providers on chronic opioid prescribing safety. J Am Board Fam Med. 2018;31:105–112. doi: 10.3122/jabfm.2018.01.170210.
    1. Jacobs SC, San EK, Tat C, Chiao P, Dulay M, Ludwig A. Implementing an opioid risk assessment telephone clinic: outcomes from a pharmacist-led initiative in a large veterans health administration primary care clinic, December 15, 2014-march 31, 2015. Subst Abus. 2016;37(1):15–19. doi: 10.1080/08897077.2015.1129527.
    1. Bauer MS, Damschroder L, Hagedorn H, Smith J, Kilbourne AM. An introduction to implementation science for the non-specialist. BMC Psychology. 2015;3(1):32. doi: 10.1186/s40359-015-0089-9.
    1. Haegerich TM, Paulozzi LJ, Manns BJ, Jones CM. What we know, and don’t know, about the impact of state policy and systems-level interventions on prescription drug overdose. Drug Alcohol Depend. 2014;145:34–47. doi: 10.1016/j.drugalcdep.2014.10.001.
    1. Kattan JA, Tuazon E, Paone D, Dowell D, Vo L, Starrels JL, et al. Public health detailing—a successful strategy to promote judicious opioid analgesic prescribing. Am J Public Health. 2016;106(8):1430–1438. doi: 10.2105/AJPH.2016.303274.
    1. Volkow ND, Koob GF, McLellan AT. Neurobiologic advances from the brain disease model of addiction. N Engl J Med. 2016;374(4):363–371. doi: 10.1056/NEJMra1511480.
    1. Mitchinson AR, Kerr EA, Krein SL. Management of chronic noncancer pain by VA primary care providers: when is pain control a priority? Am J Manag Care. 2008;14(2):77–84.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe